Cargando…
A Pilot Study to Predict Risk of IgA Nephropathy Progression Based on miR-204 Expression
INTRODUCTION: Immunoglobulin (Ig)A nephropathy (IgAN) is the most frequently diagnosed primary glomerulonephritis worldwide. Despite the common diagnostic feature of mesangial IgA-containing immune complex deposition, the clinical course of the disease is extremely variable, with 30% of patients dev...
Autores principales: | Pawluczyk, Izabella, Nicholson, Matthew, Barbour, Sean, Er, Lee, Selvaskandan, Haresh, Bhachu, Jasraj S., Barratt, Jonathan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8343780/ https://www.ncbi.nlm.nih.gov/pubmed/34386667 http://dx.doi.org/10.1016/j.ekir.2021.05.018 |
Ejemplares similares
-
The Non-Coding RNA Landscape in IgA Nephropathy—Where Are We in 2021?
por: Pawluczyk, Izabella Z. A., et al.
Publicado: (2021) -
MicroRNAs: a new avenue to understand, investigate and treat immunoglobulin A nephropathy?
por: Selvaskandan, Haresh, et al.
Publicado: (2018) -
New strategies and perspectives on managing IgA nephropathy
por: Selvaskandan, Haresh, et al.
Publicado: (2019) -
New Insights into the Pathogenesis and Treatment Strategies in IgA Nephropathy
por: Scionti, Katrin, et al.
Publicado: (2021) -
Monitoring Immune Responses in IgA Nephropathy: Biomarkers to Guide Management
por: Selvaskandan, Haresh, et al.
Publicado: (2020)